+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Advances in Vaccine Technology · Registering as Listener

ICAVT
📅 4 – 5 Mar 2027 📍 Tripoli, Libya 👥 Standard / Physical Participation
Listener Registration From
$150
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Advances in Vaccine Technology
ModeStandard / Physical
ParticipationListener
Registration fee$150.00
Bank charges (5.8%)$8.70
Total payable $158.70

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 9 SDG 10

This track focuses on novel delivery methods that enhance vaccine efficacy and accessibility. Discussions will include advancements in microneedle patches, oral vaccines, and other innovative approaches.

This session will explore the challenges and solutions related to the cold chain logistics essential for vaccine distribution. Emphasis will be placed on new technologies and strategies that ensure vaccine stability and efficacy during transport.

This track will cover the latest developments in vaccine formulation techniques aimed at improving immunogenicity and safety. Topics will include the use of novel excipients and formulation strategies for various vaccine types.

This session will delve into the role of adjuvants in enhancing vaccine responses. Participants will discuss recent breakthroughs in adjuvant research and their implications for next-generation vaccines.

This track will highlight the application of nanoparticle systems in vaccine development. Focus will be on their potential to improve immune responses and provide controlled release of antigens.

This session will explore innovative controlled release mechanisms designed to enhance vaccine effectiveness. Discussions will include polymer-based systems and their role in sustained antigen delivery.

This track will address the critical issue of vaccine stability and the methods employed to ensure long-term efficacy. Topics will include lyophilization, formulation adjustments, and storage innovations.

This session will examine the emerging trends in next-generation vaccines, including mRNA and vector-based platforms. Participants will discuss the scientific, regulatory, and public health challenges associated with these innovations.

This track will focus on platform technologies that facilitate rapid vaccine development against emerging infectious diseases. Emphasis will be placed on modular systems that can be adapted for various pathogens.

This session will discuss the regulatory landscape surrounding vaccine development and approval processes. Participants will explore how innovations in vaccine technology are influencing regulatory frameworks.

This track will address the global disparities in vaccine access and the technological innovations aimed at overcoming these barriers. Discussions will include strategies for equitable distribution and community engagement.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED